Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ryanodex for Exertional Heat Stroke
NCT02513095Phase 2Completed
- Sponsor
- Eagle Pharmaceuticals
- Start
- Sep 2015
- Primary completion
- Sep 2015
- Countries
- 1
01
Overview
A Phase 2 trial of dantrolene in exertional heat stroke (EHS), sponsored by Eagle Pharmaceuticals. Started Sep 2015; status: completed.
02
Drugs
dantrolene
03
Conditions
exertional heat stroke (EHS)
Beyond the preview
Go deeper on NCT02513095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02513095.